Affiliation:
1. National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS 38677, United States
2. Department of Chemistry, Zhejiang University, Hangzhou-310058, China
Abstract
Indoxamycins A-F, a novel class of polyketides, were isolated from the saline culture
of marine-derived actinomyces by Sato et al. in 2009. Intriguing stereochemical complexity
involving tricyclic [5.5.6] cage-like structures with six consecutive chiral centers challenged
many organic chemists. Chemical ingenuity, implementation of pioneered reactions
along with fine chemical transformations allowed not only the rapid construction of the central
core but also allowed minor structural revision and paved the information to delineate the
absolute stereostructures of these complex polyketide marine natural products. To achieve the
central core structure in indoxamycins A-F, reactions like the Ireland-Claisen rearrangement,
an enantioselective 1,6-enyne reductive cyclization, and one-pot cascade reactions of 1,2-
addition/oxa-Michael/methylenation were employed. Using the chiral pool approach, the
readily available R-carvone was employed as a cost-effective starting material to achieve the concise total syntheses
of (-)-indoxamycins A and B, in which Pauson-Khand, Cu-catalyzed Michael addition and tandem retro-oxa-Michael
addition/1,2-addition/oxa-Michael addition reactions were employed. The antipodes, (+)-indoxamycins can be easily
accessed by simply switching to S-carvone as the starting material. Synthetically prepared indoxamycins A-F are devoid
of antiproliferative properties, which disagree with the work reported by Sato and co-workers for (-)-
indoxamycins A and F. Nevertheless, ready access to such complex natural products allows probing the untapped
potential biological activities of these polyketides including cytotoxicity. A concise overview of interesting, key
chemical transformations including named reactions in establishing the architecture of indoxamycins was compiled to
inspire organic chemists and help reinvigorate novel strategies for the asymmetric synthesis as well as the development
of novel derivatives of indoxamycins with unique physicochemical and biological properties.
Publisher
Bentham Science Publishers Ltd.